6Green WR,Chan CC, Hutchins GM,et al. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases[J]. Trans Am Ophthalmol Soc , 1981,79:371 - 422.
7Perler B. Thrombolytic therapies: the current state of affairs [J]. J Endovasc Ther ,2005,12(2) :224 - 232.
8Hattenbach LO, Steinkamp G, Scharrer I, et al. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion[J]. Ophthalmologica, 1998, 212(6) :394- 398.
9A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO Ⅲ) Investigators[J]. N Engl J Med,1997,337(16):1 118-1 123.
10Smalling RW, Bode C, Kalbfieish J, et al. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteptase infusion in acute myocardial infarction. RAPID Investigators [J ]. Circulation, 199.5,91 ( 11 ) : 2 725 - 2 732.
